Syndrome De Moschowitz Et Grossesse A Propos Daun Cas Avec Revue De La Litterature

1
souad mezzane
souad mezzane
2
S.Mezane
S.Mezane
3
M. Achenani
M. Achenani
4
M.Ziyadi
M.Ziyadi
5
R. Hafidi
R. Hafidi
6
I.Hakimi
I.Hakimi
7
A. Babahabib
A. Babahabib
8
D.Moussaoui
D.Moussaoui
9
M. Dehayni
M. Dehayni
1 Universit Mohamed V Souissi

Send Message

To: Author

GJMR Volume 14 Issue E3

Article Fingerprint

ReserarchID

K6HI1

Syndrome De Moschowitz Et Grossesse A Propos Daun Cas Avec Revue De La Litterature Banner
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Thrombotic thrombocytopenic purpura (TTP) is a form of thrombotic microangiopathy (TMA) particularly serious because it can be accompanied by a multi-organ failure. Post-mortem studies in these patients revealed the presence of thrombi in the microcirculation of most organs, suggesting that the TTP is a multi-systemic disease.We distinguish sporadic PTT, which permanently cures the PTT recurrent, on the contrary characterized by regular and frequent relapses and intermittent PTT, where relapses occur with irregular frequency.Different types of MAT may encounter during pregnancy and postpartum, as PTT, HUS and HELLP syndrome.The latter is a more specific form of MAT of pregnancy and postpartum, it is sometimes difficult to distinguish TTP and HUS.. This distinction can be based on hepatic dysfunction and disseminated intravascular coagulation, present in the HELLP syndrome and absent in TTP and HUS. Some HUS occurring during postpartum may be related to a heterozygous mutation in the Factor H gene (E. Rondeau, personal communication).Treatment of TTP in pregnancy is also based on the achievement of plasma exchange. Pregnancy does not affect the response to treatment of TTP.

45 Cites in Articles

References

  1. T Gernsheimer,K Mccrae (2007). Immune thrombocytopenic purpura in pregnancy.
  2. S Sainio,R Kekomaki,S Riikonen,K Teramo (2000). Maternal thrombocytopenia at term: a population-based study.
  3. Robert Burrows,John Kelton (1990). Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura.
  4. Françoise Boehlen,Patrick Hohlfeld,Philippe Extermann,Thomas Perneger,Philippe De Moerloose (2000). Platelet Count at Term Pregnancy.
  5. Hisanori Minakami,Tomoyuki Kuwata,Ikuo Sato (1996). Gestational thrombocytopenia: Is it new?.
  6. P Abrahamson,S Hall,M Feudjo-Tepie,F Mitrani-Gold,J (2009). LogieThe incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review.
  7. W Schoonen,G Kucera,J Coalson,L Li,M Rutstein,F Mowat (2009). Epidemiology of immune thrombocytopenic purpura in the general practice research database.
  8. K Mccrae,D (1997). Cines Thrombotic microangiopathy during pregnancy.
  9. C Weiner (1987). Thrombotic microangiopathy in pregnancy and the post-partum period.
  10. Reinhard Schneppenheim,Ulrich Budde,Florian Oyen,Dorothea Angerhaus,Volker Aumann,Elke Drewke,Wolf Hassenpflug,Johannes Häberle,Karim Kentouche,Elisabeth Kohne,Karin Kurnik,Dirk Mueller-Wiefel,Tobias Obser,René Santer,Karl-Walter Sykora (2003). von Willebrand factor cleaving protease and ADAMTS13mutations in childhood TTP.
  11. W Bell,H Braine,P Ness,T (1991). KichlerImproved survival thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patientN.
  12. Gail Rock,Kenneth Shumak,Noel Buskard,Victor Blanchette,John Kelton,Rama Nair,Robert Spasoff (1991). Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura.
  13. Paul Coppo,Annette Bussel,Sabine Charrier,Christophe Adrie,Lionel Galicier,Emmanuelle Boulanger,Agnès Veyradier,Thierry Leblanc,Corinne Alberti,Elie Azoulay,Jean-Roger Le Gall,Benoît Schlemmer (2003). High-Dose Plasma Infusion versus Plasma Exchange as Early Treatment of Thrombotic Thrombocytopenic Purpura/Hemolytic-Uremic Syndrome.
  14. Nicholas Novitzky,Peter Jacobs,Wilhelm Rosenstrauch (1994). The treatment of thrombotic thrombocytopenic purpura: plasma infusion or exchange?.
  15. M Furlan,R Robles,B Morselli,P Sandoz,B (1999). Lämml Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in with thrombotic thrombocytopenic purpuraThromb.
  16. G Del (1987). Zoppo Antiplatelet therapy in thrombotic thrombocytopenic purpuraSemin.
  17. V Roy,M Rizvi,S Vesely,J George (2001). Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes.
  18. Thomas Gaddis,Troy Guthrie,Mary Drew,Mervyn Sahud,Robert Howe,Abraham Mittelman (1997). Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption.
  19. S Meggitt,A Anstey,M Mohd Mustapa,N Reynolds,S Wakelin,M Tidman,L Fuller,J Mclelland,J Lear,J Hughes,A Mcdonagh,S Punjabi,N Morar,D Buckley,I Nasr,P Maycock,S Amin,S Hulley,S Haveron (2011). British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011.
  20. Nathalie Costedoat-Chalumeau,Zahir Amoura,Du Huong,Philippe Lechat,Jean-Charles Piette (2005). Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature.
  21. Eliza Chakravarty,Elaine Murray,Ariella Kelman,Pamela Farmer (2011). Pregnancy outcomes after maternal exposure to rituximab.
  22. Paul Imbach,Mark Crowther (2011). Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia.
  23. D Harkness,J Byrnes,E Lian,W Williams,G (1981). HensleyHazard of platelet transfusion in thrombotic thrombocytopenic purpur.
  24. A Creager,M Brecher,N Bandarenko (1998). Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection.
  25. (2003). Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.
  26. J George,S Woolf,G Raskob,J Wasser,L Aledort,P Ballem,V Blanchette,J Bussel,D Cines,J Kelton,A Lichtin,R Mcmillan,J Okerbloom,D Regan,I Warrier (1996). Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments].
  27. Kathryn Webert,Richa Mittal,Christopher Sigouin,Nancy Heddle,John Kelton (2003). A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura.
  28. A Valat,M Caulier,P Devos,L Rugeri,B Wibaut,P Vaast (1998). Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocy-topenia.
  29. Hideaki Lyori,Kohji Fujisawa,Jun-Ichi Akatsuka (1997). Thrombocytopenia in Neonates Born to Women with Autoimmune Thrombocytopenic Purpura.
  30. Karamjit Gill,John Kelton (2000). Management of idiopathic thrombocytopenic purpura in pregnancy.
  31. Drew Provan,Roberto Stasi,Adrian Newland,Victor Blanchette,Paula Bolton-Maggs,James Bussel,Beng Chong,Douglas Cines,Terry Gernsheimer,Bertrand Godeau,John Grainger,Ian Greer,Beverley Hunt,Paul Imbach,Gordon Lyons,Robert Mcmillan,Francesco Rodeghiero,Miguel Sanz,Michael Tarantino,Shirley Watson,Joan Young,David Kuter (2010). International consensus report on the investigation and management of primary immune thrombocytopenia.
  32. R Ali,F Ozkalemkas,T Ozcelik,V Ozkocaman,U Ozan,Y Kimya (2003). Idiopathic thrombocytopenic purpura in pregnancy: a single institutional experience with maternal and neonatal outcomes.
  33. Vanita Suri,Neelam Aggarwal,Shilpi Saxena,Pankaj Malhotra,Subhash Varma (2006). Maternal and perinatal outcome in idiopathic thrombocytopenic purpura (ITP) with pregnancy.
  34. V Loustau,L Baili,M Khellaf,L Languille,P Bierling,B Haddad (2012). Influence de la grossesse sur l'évolution du purpura thrombopénique immunologique : analyse rétrospective de 80 grossesses.
  35. O Debouverie,P Roblot,F Roy-Péaud,C Boinot,F Pierre,O Pourrat (2011). Évolution du PTI en cours de grossesse: étude rétrospective de 62 grossesses.
  36. Lorence Gutterman,T Stevenson (1982). Treatment of Thrombotic Thrombocytopenic Purpura With Vincristine.
  37. J Welborn,P Emrick,M Acevedo (1990). Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis.
  38. P Wong,K Itoh,S (1986). YoshidaTreatment of thrombotic thrombocytopenic purpura with intravenous ùgamma globulin N.
  39. Jenniferm. Bird,David Cummins,Samuelj. Machin (1990). Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura.
  40. M Crowther,N Heddle,C Hayward,T Warkentin,J (1996). KeltonSplenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura.
  41. M Furlan,R Robles,M Galbusera,G Remuzzi,P Kyrle,B Brenner (1998). VonWillebrand factorcleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N.
  42. Roslyn Yomtovian,Waldemar Niklinski,Bernard Silver,Ravindra Sarode,Han‐mou Tsai (2004). Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
  43. Michal Rose,Amiram Eldor (1987). High incidence of relapses in thrombotic thrombocytopenic purpura.
  44. Jeffrey Patton,Kenneth Manning,Douglas Case,John Owen (1994). Serum lactate dehydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura.
  45. X Zheng,Richard Kaufman,Lawrence Goodnough,J Sadler (2004). Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

souad mezzane. 2014. \u201cSyndrome De Moschowitz Et Grossesse A Propos Daun Cas Avec Revue De La Litterature\u201d. Global Journal of Medical Research - E: Gynecology & Obstetrics GJMR-E Volume 14 (GJMR Volume 14 Issue E3): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Classification
Not Found
Version of record

v1.2

Issue date

September 13, 2014

Language

English

Experiance in AR

The methods for personal identification and authentication are no exception.

Read in 3D

The methods for personal identification and authentication are no exception.

Article Matrices
Total Views: 4348
Total Downloads: 2273
2026 Trends
Research Identity (RIN)
Related Research

Published Article

Thrombotic thrombocytopenic purpura (TTP) is a form of thrombotic microangiopathy (TMA) particularly serious because it can be accompanied by a multi-organ failure. Post-mortem studies in these patients revealed the presence of thrombi in the microcirculation of most organs, suggesting that the TTP is a multi-systemic disease.We distinguish sporadic PTT, which permanently cures the PTT recurrent, on the contrary characterized by regular and frequent relapses and intermittent PTT, where relapses occur with irregular frequency.Different types of MAT may encounter during pregnancy and postpartum, as PTT, HUS and HELLP syndrome.The latter is a more specific form of MAT of pregnancy and postpartum, it is sometimes difficult to distinguish TTP and HUS.. This distinction can be based on hepatic dysfunction and disseminated intravascular coagulation, present in the HELLP syndrome and absent in TTP and HUS. Some HUS occurring during postpartum may be related to a heterozygous mutation in the Factor H gene (E. Rondeau, personal communication).Treatment of TTP in pregnancy is also based on the achievement of plasma exchange. Pregnancy does not affect the response to treatment of TTP.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]
×

This Page is Under Development

We are currently updating this article page for a better experience.

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Syndrome De Moschowitz Et Grossesse A Propos Daun Cas Avec Revue De La Litterature

S.Mezane
S.Mezane
M. Achenani
M. Achenani
M.Ziyadi
M.Ziyadi
R. Hafidi
R. Hafidi
I.Hakimi
I.Hakimi
A. Babahabib
A. Babahabib
D.Moussaoui
D.Moussaoui
M. Dehayni
M. Dehayni

Research Journals